These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25481201)

  • 1. The reply.
    Bangalore S; Messerli FH
    Am J Med; 2014 Dec; 127(12):e19. PubMed ID: 25481201
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP journal club. Review: β-blockers do not reduce mortality in myocardial infarction in the reperfusion era.
    Borzak S
    Ann Intern Med; 2015 Mar; 162(6):JC3. PubMed ID: 25775346
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical outcomes with beta-blockers after myocardial infarction: finding the right patient and the right regimen.
    Jennings DL; Miyares MA
    Am J Med; 2014 Dec; 127(12):e17. PubMed ID: 25481200
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.
    Bangalore S; Makani H; Radford M; Thakur K; Toklu B; Katz SD; DiNicolantonio JJ; Devereaux PJ; Alexander KP; Wetterslev J; Messerli FH
    Am J Med; 2014 Oct; 127(10):939-53. PubMed ID: 24927909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial reperfusion injury.
    Ibanez B; Cimmino G; Badimon JJ
    N Engl J Med; 2007 Dec; 357(23):2409; author reply 2409-10. PubMed ID: 18069135
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of acute ST-segment elevation myocardial infarction. II. Beyond reperfusion.
    Glancy DL; Subramaniam PN; Pappas ND; Lewis RS
    J La State Med Soc; 2002; 154(5):235-40; quiz 240. PubMed ID: 12440750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the success of fibrinolysis: can we let the interventionalist rest?
    Morrow DA; de Lemos JA
    Am Heart J; 2003 Mar; 145(3):380-2. PubMed ID: 12660657
    [No Abstract]   [Full Text] [Related]  

  • 8. Age differences in the adherence to treatment guidelines and outcome in patients with ST-elevation myocardial infarction.
    Gottlieb S; Behar S; Schwartz R; Harpaz D; Shotan A; Zahger D; Hod H; Tzivoni D; Moriel M;
    Arch Gerontol Geriatr; 2011; 52(1):118-24. PubMed ID: 20399515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intravenous beta-blockers in the treatment of ST-elevation myocardial infarction: of mice (dogs, pigs) and men.
    Bates ER
    Circulation; 2007 Jun; 115(23):2904-6. PubMed ID: 17562966
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of STEMI in low- and middle-income countries.
    Baliga RR; Bahl VK; Alexander T; Mullasari A; Manga P; Dec GW; Narula J
    Glob Heart; 2014 Dec; 9(4):469-510. PubMed ID: 25592801
    [No Abstract]   [Full Text] [Related]  

  • 11. Author's reply to Wolstenholme and Sanfilippo and colleagues.
    Quint JK
    BMJ; 2014 Jan; 348():g1132. PubMed ID: 24477012
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-adrenergic blocking drugs after acute myocardial infarction.
    Shand DG
    Mod Concepts Cardiovasc Dis; 1982 Jul; 51(7):103-6. PubMed ID: 6126802
    [No Abstract]   [Full Text] [Related]  

  • 13. β-Blocker use for patients with or at risk for coronary artery disease--reply.
    Bangalore S; Steg PG; Bhatt DL
    JAMA; 2013 Feb; 309(5):439-40. PubMed ID: 23385261
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modulation of the beta-adrenergic system during acute myocardial infarction: rationale for a new clinical trial].
    Ibáñez B; Fuster V; Macaya C; Jiménez-Borreguero J; Iñiguez A; Fernández-Ortiz A; Sanz G; Sánchez-Brunete V
    Rev Esp Cardiol; 2011 Jul; 64 Suppl 2():28-33. PubMed ID: 21807284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myocardial infarction care improved, but still inadequate.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Aug; 14(15):1-2, 5. PubMed ID: 12964576
    [No Abstract]   [Full Text] [Related]  

  • 16. Older emergency department patients with acute myocardial infarction receive lower quality of care than younger patients.
    Magid DJ; Masoudi FA; Vinson DR; van der Vlugt TM; Padgett TG; Tricomi AJ; Lyons EE; Crounse L; Brand DW; Go AS; Ho PM; Rumsfeld JS
    Ann Emerg Med; 2005 Jul; 46(1):14-21. PubMed ID: 15988420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta blockaders and threatened myocardial infarction].
    S Afr Med J; 1979 Feb; 55(6):191. PubMed ID: 35842
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-blockers in acute myocardial infarction.
    Kumar S; Bandopadhyay S
    Indian Heart J; 2011; 63(1):66-70. PubMed ID: 23189867
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacotherapy: Current role of β-blockers after MI in patients without HF.
    Mukherjee D; Eagle KA
    Nat Rev Cardiol; 2016 Dec; 13(12):699-700. PubMed ID: 27786237
    [No Abstract]   [Full Text] [Related]  

  • 20. Saving lives after myocardial infarction: the role of beta-adrenergic blockers.
    Frishman WH
    Mt Sinai J Med; 1990 Mar; 57(2):75-84. PubMed ID: 1973260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.